Trade Spotlight: How should you trade Pidilite, Fortis Healthcare, Sun Pharma, Emcure, Tata Consumer Products, and others on January 7?

Top Buy Ideas for January 7

• Experts picked top 8 buy ideas for January 7 including Pidilite Industries, Fortis Healthcare, Sun Pharma, Emcure, and Tata Consumer Products

Did our AI summary help?

The benchmarks extended their downtrend for another session on January 6, falling by one-third of a percent again, with further weakening market breadth. A total of 1,801 shares declined, while 1,054 shares advanced on the NSE. Consolidation is expected to continue in the market for the next few sessions. Below are some short-term trading ideas to consider:

Amol Athawale, VP Technical Research at Kotak Securities

Pidilite Industries | CMP: Rs 1,505

On the daily scale, post correction from higher levels, Pidilite Industries was trading in a range-bound mode. However, it has delivered a range breakout along with decent volumes. Therefore, a close above the resistance line indicates that further bullish momentum could continue in the coming period.

For positional traders, Rs 1,455 would be the decisive level. Trading above this level, the uptrend formation may continue towards Rs 1,600. However, if the stock closes below Rs 1,455, traders may prefer to exit long positions.

Strategy: Buy

Target: Rs 1,600

Stop-Loss: Rs 1,455

Life Insurance Corporation of India | CMP: Rs 850

Post its downward trend, LIC is in an accumulation zone, where it has been trading in a range-bound mode on the daily scale. However, recent bullish activity in the stock is indicating good strength. The stock is expected to break out of the range and witness bullish momentum from the current levels with a favourable risk-reward perspective.

For the next few trading sessions, Rs 820 could be the trend-decider level for the bulls. If it sustains above this level, further upside towards Rs 910 can be expected.

Strategy: Buy

Target: Rs 910

Stop-Loss: Rs 820

Nagaraj Shetti, Senior Technical Research Analyst at HDFC Securities

Sun Pharmaceutical Industries | CMP: Rs 1,760.2

After showing weakness in the last few weeks, Sun Pharma has witnessed a sharp upside breakout so far this week amid a volatile broader market. The stock price moved above the crucial resistance of the 10- and 20-week EMAs on Tuesday and closed higher. Hence, there is a higher possibility of a further extension of upside momentum in the coming week. Volumes have started to expand during the upside breakout in the stock price, and the weekly 14-period RSI shows positive indications.

Strategy: Buy

Target: Rs 1,905

Stop-Loss: Rs 1,685

Emcure Pharmaceuticals | CMP: Rs 1,528

Emcure Pharma has witnessed a sharp breakout so far this week. The larger consolidation has been decisively surpassed around Rs 1,470, with the stock closing higher. The weekly candlestick pattern indicates a change in sentiment towards bullishness. The larger positive sequence of higher tops and higher bottoms remains intact as per the weekly timeframe chart. Volumes expanded on Tuesday during the breakout, and the weekly 14-period RSI shows positive indications.

Strategy: Buy

Target: Rs 1,655

Stop-Loss: Rs 1,458

NAVA | CMP: Rs 611.2

After showing range-bound action over the last few weeks, NAVA has witnessed a decisive upside breakout at the Rs 440 level so far this week and closed higher. The weekly candlestick pattern indicates a decisive upside breakout of the larger consolidation pattern.

The larger positive sequence of higher tops and higher bottoms remains intact as per the weekly timeframe chart. Volumes expanded on Tuesday during the breakout in the stock price, and the weekly 14-period RSI shows positive indications.

Strategy: Buy

Target: Rs 660

Stop-Loss: Rs 580

Ashish Kyal, CMT, Founder and CEO of Waves Strategy Advisors

Fortis Healthcare | CMP: Rs 945

On the daily chart, Fortis Healthcare has been moving under the formation of a rounding bottom pattern since November 2025. In the previous session, the stock surged more than 3% and also closed above the neckline at Rs 941, confirming the breakout of the pattern.

Also, over the past four trading sessions, prices have not closed below the previous day’s low, which confirms strength in the ongoing trend. The stock also closed above the 50 EMA (Exponential Moving Average), which is a positive sign. For now, one can use dips as a buying opportunity for a move towards Rs 985, followed by Rs 1,030 levels.

Strategy: Buy

Target: Rs 985, Rs 1,030

Stop-Loss: Rs 895

Aurobindo Pharma | CMP: Rs 1,231.3

At the start of this month, Aurobindo Pharma took support near its 60-day EMA and has since resumed an upward move, forming a clear higher-high and higher-low structure. The stock is currently on the verge of a breakout from an inverse head-and-shoulders pattern, indicating a potential bullish trend reversal.

In the previous session, prices closed with gains of 2%, reflecting strong buying interest. Also, the MACD has shown a bullish crossover, with a green histogram forming above the zero line, which is acting as a double confirmation. A decisive breakout above the neckline resistance of Rs 1,242 can confirm the pattern breakout and push prices higher towards the pattern target of Rs 1,320 or beyond.

Strategy: Buy

Target: Rs 1,320

Stop-Loss: Rs 1,190

Tata Consumer Products | CMP: Rs 1,210.4

Tata Consumer Products has been respecting an upward-sloping trendline since August 2025. Recently, prices once again took support near this trendline and rebounded by more than 4%, underlining its significance. In the previous session, the stock decisively broke above its prior swing high of Rs 1,202 and closed with gains of 2.39%, clearly indicating that bulls remain in control.

Along with this, the ADX is trading near 29, suggesting strengthening bullish momentum in the stock. For now, a buy-on-dips strategy appears prudent to ride the ongoing trend, with upside targets of Rs 1,250 followed by Rs 1,280. On the downside, Rs 1,165 remains a crucial support level, which also coincides with the rising trendline.

Strategy: Buy

Target: Rs 1,250, Rs 1,280

Stop-Loss: Rs 1,165